Resumen

RODRIGUEZ-VAZQUEZ, Virginia et al. Basophil activation test to follow-up of patients treated with hymenoptera venom immunotherapy: a review of current evidence. Rev. alerg. Méx. [online]. 2022, vol.69, n.3, pp.125-137.  Epub 19-Mayo-2023. ISSN 2448-9190.  https://doi.org/10.29262/ram.v69i3.1135.

Hymenoptera venom immunotherapy (HVI) is a long-term effective treatment to avoid new systemic reactions in patients with Hymenoptera allergy. The sting challenge test is considered the gold standard to confirm the tolerance. However, the use of this technique is not generalized in clinical practice, being the basophil activation test (BAT), which functionally explores allergen response, an alternative that does not entail any of the provocation risks associated with the sting challenge test. This study reviews the publications that used the BAT to follow up and evaluate the success of the HVI. Studies assessing the changes between a baseline BAT before the start and BATs performed between the starting and maintenance phases of the HVI were selected. Ten articles were found, comprising information from 167 patients, of which 29% used the sting challenge test. The studies concluded the importance of evaluating the responses with submaximal allergen concentrations, which reflect basophil sensitivity, to monitor the HVI using the BAT. It was also observed that changes in the maximum response (reactivity) could not reflect the clinical status of tolerance, particularly in the initial phases of HVI.

Palabras llave : Hymenoptera venom; Immunotherapy; Basophil activation test; Immune tolerance.

        · resumen en Español     · texto en Español     · Español ( pdf )